Compound Summary
Compound Name: | 3',4'-Dichlorobenzamil |
Compound CID: | 114771 |
Synonyms: | "3,4-Dichlorobenzamil dichlorobenzamil 3,4-dichlorobenzamil 1166-01-4 GNF-Pf-1778 More... |
Iupac Name: | 3,5-diamino-6-chloro-N-[N'-[(3,4-dichlorophenyl)methyl]carbamimidoyl]pyrazine-2-carboxamide |
InChI: | InChI=1S/C13H12Cl3N7O/c14-6-2-1-5(3-7(6)15)4-20-13(19)23-12(24)8-10(17)22-11(18)9(16)21-8/h1-3H,4H2,(H4,17,18,22)(H3,19,20,23,24) |
InChIKey: | OSHKWEFWXCCNJR-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC(=C(C=C1CN=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N)Cl)Cl |
Isomeric Smiles: | C1=CC(=C(C=C1CN=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N)Cl)Cl |
Molecular Weight: | 388.6 |
Molecular Formula: | C13H12Cl3N7O |
Molecular Weight: | 388.6 |
Molecular Formula: | C13H12Cl3N7O |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 24 |
Complexity: | 481 |
3',4'-Dichlorobenzamil | 3',4'-Dichlorobenzamil |
---|---|
"3,4-Dichlorobenzamil |
dichlorobenzamil |
3,4-dichlorobenzamil |
1166-01-4 |
GNF-Pf-1778 |
3,5-diamino-6-chloro-N-N-(3,4-dichlorophenyl)methylcarbamimidoylpyrazine-2-carboxamide" |
3,4-Dichlorobenzamil hydrochloride" |
3,5-diamino-6-chloro-N-N-(3,4-dichlorophenyl)methylcarbamimidoylpyrazine-2-carboxamide;hydrochloride |
L-594,881 |
Lopac-D-8190 |
Lopac0_000413 |
CHEMBL587714 |
GTPL4597 |
SCHEMBL10844588 |
DTXSID30922105 |
CHEBI:125553 |
ZINC9226184 |
MFCD03839362 |
CCG-204505 |
NCGC00015373-01 |
NCGC00015373-02 |
NCGC00162146-01 |
BRD-K41049123-001-01-3 |
Q27073358 |
3,5-Diamino-6-chloro-N-(((3,4-dichlorophenyl)amino)iminomethyl)pyrazinecarboxamide |
3,5-Diamino-6-chloro-N-(N-(3,4-dichlorobenzyl)carbamimidoyl)pyrazine-2-carboxamide |
Pyrazinecarboxamide, 3,5-diamino-6-chloro-N-(((3,4-dichlorophenyl)amino)iminomethyl)- |
2-Pyrazinecarboxamide,3,5-diamino-6-chloro-N-(3,4-dichlorophenyl)methylaminoiminomethyl- |
3,5-diamino-6-chloro-N-(E)-N-(3,4-dichlorophenyl)methylcarbamimidoylpyrazine-2-carboxamide |
3,5-Diamino-6-chloro-N-{N-(3,4-dichlorophenyl)methylcarbamimidoyl}pyrazine-2-carboximidic acid |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33 | umol/L | -25 | NS | N2 | 24134630 | Inactive |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | -25 | 1 | 1 |